Of the active trials in the Alzheimer's Disease pipeline, ** percent were for drugs and *** percent were for biologicals, as of 2022. This statistic depicts the number of active trials for Alzheimer’s Disease products in the global pipeline as of 2022, by product type.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆÆ½â°æ can support your business.
IQVIA, & EFPIA. (August 29, 2022). Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type [Graph]. In ÌÇÐÄÆÆ½â°æ. Retrieved July 28, 2026, from /statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA, und EFPIA. "Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type." Chart. August 29, 2022. ÌÇÐÄÆÆ½â°æ. Accessed July 28, 2026. /statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA, EFPIA. (2022). Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type. ÌÇÐÄÆÆ½â°æ. ÌÇÐÄÆÆ½â°æ Inc.. Accessed: July 28, 2026. /statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA, and EFPIA. "Share of Active Trials for Alzheimer’s Disease in The Global Pipeline as of 2022, by Product Type." ÌÇÐÄÆÆ½â°æ, ÌÇÐÄÆÆ½â°æ Inc., 29 Aug 2022, /statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/
IQVIA & EFPIA, Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type ÌÇÐÄÆÆ½â°æ, /statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/ (last visited July 28, 2026)
Share of active trials for Alzheimer’s Disease in the global pipeline as of 2022, by product type [Graph], IQVIA, & EFPIA, August 29, 2022. [Online]. Available: /statistics/1249738/share-active-trials-alzheimers-by-product-type-worldwide/